In the final days of the 2007 Congressional session, the U.S. Senate and House of Representatives provided a 6-month reprieve from a scheduled 10.1% cut in Medicare reimbursements for physicians.
In the final days of the 2007 Congressional session, the U.S. Senate and House of Representatives provided a 6-month reprieve from a scheduled 10.1% cut in Medicare reimbursements for physicians. Instead, physicians were given a 0.5% increase. But unless Congress acts before June 30, the 10.1% reduction will go back into effect as if the reprieve never happened.
The American Medical Association and other groups were thankful for the reprieve but disappointed with the temporary nature of the bill. "We strongly urge Congress to break the tradition of short-term interventions that are not funded and fail to chart a course for replacing a flawed payment formula that is a barrier to improving quality and access to care for seniors," AMA Board of Trustees Chair Edward Langston, MD, told American Medical News (1/7/2008).
The AMA had been lobbying Congress to enact 2-year pay raises to reflect the rising cost of providing medical care. But party lines got in the way. While Senate Democrats got behind a 2-year update, Senate Republicans threatened to block the measure. To pass both houses and gain President Bush's signature, the compromise was the 6-month reprieve from a double-digit cut.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More